GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Genesystem Co Ltd (XKRX:363250) » Definitions » EV-to-Revenue

Genesystem Co (XKRX:363250) EV-to-Revenue : 57.41 (As of May. 27, 2024)


View and export this data going back to 2021. Start your Free Trial

What is Genesystem Co EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Genesystem Co's enterprise value is ₩32,119.2 Mil. Genesystem Co's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 was ₩559.5 Mil. Therefore, Genesystem Co's EV-to-Revenue for today is 57.41.

The historical rank and industry rank for Genesystem Co's EV-to-Revenue or its related term are showing as below:

XKRX:363250' s EV-to-Revenue Range Over the Past 10 Years
Min: 1.66   Med: 6.24   Max: 109.62
Current: 57.41

During the past 5 years, the highest EV-to-Revenue of Genesystem Co was 109.62. The lowest was 1.66. And the median was 6.24.

XKRX:363250's EV-to-Revenue is ranked worse than
93.27% of 223 companies
in the Medical Diagnostics & Research industry
Industry Median: 3.23 vs XKRX:363250: 57.41

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-05-27), Genesystem Co's stock price is ₩6010.00. Genesystem Co's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 was ₩80.40. Therefore, Genesystem Co's PS Ratio for today is 74.76.


Genesystem Co EV-to-Revenue Historical Data

The historical data trend for Genesystem Co's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Genesystem Co EV-to-Revenue Chart

Genesystem Co Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-Revenue
- - 3.42 9.75 65.26

Genesystem Co Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
EV-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 21.50 85.88 97.03 65.26 114.59

Competitive Comparison of Genesystem Co's EV-to-Revenue

For the Diagnostics & Research subindustry, Genesystem Co's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Genesystem Co's EV-to-Revenue Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Genesystem Co's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Genesystem Co's EV-to-Revenue falls into.



Genesystem Co EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Genesystem Co's EV-to-Revenue for today is calculated as:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=32119.221/559.45
=57.41

Genesystem Co's current Enterprise Value is ₩32,119.2 Mil.
Genesystem Co's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩559.5 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Genesystem Co  (XKRX:363250) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Genesystem Co's PS Ratiofor today is calculated as:

PS Ratio=Share Price (Today)/Revenue per Share (TTM)
=6010.00/80.395
=74.76

Genesystem Co's share price for today is ₩6010.00.
Genesystem Co's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩80.40.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Genesystem Co EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Genesystem Co's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Genesystem Co (XKRX:363250) Business Description

Traded in Other Exchanges
N/A
Address
200-9, Techno 2-ro, Yuseong-gu, Daejeon, KOR, 34028
Genesystem Co Ltd is a biotech engineering company specializing in molecular testing solutions that target on-site testing needs. It develops and markets state-of-the-art PCR platforms as well as related reagents and biochip products designed to enhance the health of human societies and improve the quality of human life.

Genesystem Co (XKRX:363250) Headlines

No Headlines